MA34453B1 - Utilisation d'une eau appauvrie en deutèrium pour traiter la résistance à l'insuline - Google Patents

Utilisation d'une eau appauvrie en deutèrium pour traiter la résistance à l'insuline

Info

Publication number
MA34453B1
MA34453B1 MA35641A MA35641A MA34453B1 MA 34453 B1 MA34453 B1 MA 34453B1 MA 35641 A MA35641 A MA 35641A MA 35641 A MA35641 A MA 35641A MA 34453 B1 MA34453 B1 MA 34453B1
Authority
MA
Morocco
Prior art keywords
insulin resistance
deuterium
treat insulin
deep
based water
Prior art date
Application number
MA35641A
Other languages
English (en)
Inventor
Gabor Somlyai
Original Assignee
Hyd Rakkutato Es Gyogyszerfejleszto Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyd Rakkutato Es Gyogyszerfejleszto Kft filed Critical Hyd Rakkutato Es Gyogyszerfejleszto Kft
Publication of MA34453B1 publication Critical patent/MA34453B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

CETTE INVENTION CONCERNE UNE EAU APPAUVRIE EN DEUTÉRIUM CONTENANT DE 0,01 À 135 PPM DE DEUTÉRIUM, DE PRÉFÉRENCE, DE 105 À 125 PPM DE DEUTÉRIUM, POUVANT ÊTRE UTILISÉE POUR TRAITER LA RÉSISTANCE À L'INSULINE. UN AUTRE OBJET DE CETTE INVENTION EST UN PRODUIT ALIMENTAIRE APPAUVRI EN DEUTÉRIUM CONTENANT DE 0,01 À 135 PPM DE DEUTÉRIUM, DE PRÉFÉRENCE, DE 105 À 125 PPM DE DEUTÉRIUM, POUVANT ÊTRE UTILISÉ POUR TRAITER LA RÉSISTANCE À L'INSULINE.
MA35641A 2010-07-08 2011-07-08 Utilisation d'une eau appauvrie en deutèrium pour traiter la résistance à l'insuline MA34453B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU1000357A HUP1000357A2 (en) 2010-07-08 2010-07-08 Pharmaceutical and food products suitable for activating of glucose-transporters
PCT/HU2011/000063 WO2012004620A2 (fr) 2010-07-08 2011-07-08 Utilisation d'une eau appauvrie en deutérium pour traiter la résistance à l'insuline

Publications (1)

Publication Number Publication Date
MA34453B1 true MA34453B1 (fr) 2013-08-01

Family

ID=89989816

Family Applications (1)

Application Number Title Priority Date Filing Date
MA35641A MA34453B1 (fr) 2010-07-08 2011-07-08 Utilisation d'une eau appauvrie en deutèrium pour traiter la résistance à l'insuline

Country Status (11)

Country Link
US (1) US20140141095A1 (fr)
EP (1) EP2590715A2 (fr)
JP (1) JP2013535415A (fr)
KR (1) KR20130139851A (fr)
CN (1) CN103068444A (fr)
AU (1) AU2011275501A1 (fr)
CA (1) CA2805313A1 (fr)
HU (1) HUP1000357A2 (fr)
MA (1) MA34453B1 (fr)
RU (1) RU2013104298A (fr)
WO (1) WO2012004620A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP1200552A2 (en) * 2012-09-21 2014-04-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Pharmaceutical compositions for the treatment of high blood pressure
CN107811968A (zh) * 2017-12-14 2018-03-20 官鲁东 低氘水在葡萄糖注射液中的应用及葡萄糖低氘水注射液
WO2019174659A1 (fr) 2018-03-15 2019-09-19 Karl Bau Gmbh Procédé et ensemble servant à fabriquer de l'eau à teneur réduite en deutérium
WO2020072279A2 (fr) * 2018-09-27 2020-04-09 Collins T Que Mesure de déplétion du deutérium

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE205055T1 (de) * 1994-01-06 2001-09-15 Hyd Kutato Fejleszto Ktf Nahrungsmittel zur verhinderung der entwicklung von erkrankungen und verfahren zur herstellung dieser nahrungsmittel
US6365176B1 (en) * 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
HU226984B1 (en) * 2001-12-12 2010-04-28 Hyd Kutato Fejlesztoe Kft Medical and food products for treating diabetes mellitus and process for producing thereof
JP2004067654A (ja) * 2002-08-06 2004-03-04 Internatl Scient:Kk 重水素減少水（スーパーライトウォーター）による糖尿病、老人性不眠症、肩こり、むち打ち症、胃潰瘍、十二指腸潰瘍の治療方法、若返り治療方法
JP2005336146A (ja) * 2004-05-27 2005-12-08 Tatsuo Usui 体内の有機物（炭水化物、脂質、蛋白質、ビタミン類、アミノ酸類）を重水素濃度の低い有機物（炭水化物、脂質、蛋白質、ビタミン類、アミノ酸類）と入れ換えることによる健康維持、若返り、病気治療、病気予防をする方法、及び重水素濃度の低い有機物（炭水化物、脂質、蛋白質、ビタミン類、アミノ酸類）を体内に取り入れるための食品の製造方法。
WO2005117566A1 (fr) * 2004-06-03 2005-12-15 Kunihiro Seki Appareil de production d’un aliment a faible concentration de deuterium
RU2270017C1 (ru) * 2004-07-08 2006-02-20 Общество с ограниченной ответственностью "Медико-технологический комплекс Айсберг" (ООО "МТК Айсберг") Способ лечения больных сахарным диабетом
US20080299221A1 (en) * 2005-12-12 2008-12-04 Igor Anatolievich Pomytkin Method for Decreasing Postprandial Glucose Excursion
EP1971350A1 (fr) * 2005-12-12 2008-09-24 VADA Consulting Limited Procede pour traiter le syndrome metabolique

Also Published As

Publication number Publication date
KR20130139851A (ko) 2013-12-23
HU1000357D0 (en) 2010-10-28
CN103068444A (zh) 2013-04-24
HUP1000357A2 (en) 2012-10-29
WO2012004620A3 (fr) 2012-04-05
AU2011275501A1 (en) 2013-02-28
WO2012004620A2 (fr) 2012-01-12
CA2805313A1 (fr) 2012-01-12
RU2013104298A (ru) 2014-08-20
US20140141095A1 (en) 2014-05-22
EP2590715A2 (fr) 2013-05-15
JP2013535415A (ja) 2013-09-12

Similar Documents

Publication Publication Date Title
FR3020060B1 (fr) Preparation d'imides contenant un groupement fluorosulfonyle
MA54411A (fr) Compositions contenant de l'ibrutinib
EA201691799A1 (ru) Бициклические соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa)
MA39246A1 (fr) Composé hétérocyclique fusionné
EA201101699A1 (ru) Синергетические фунгицидные смеси
TN2009000291A1 (en) Inhibitors of mek
EA201691794A1 (ru) Конденсированные [1,4]диазепиновые соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa)
EA201891336A1 (ru) Гетероарилгидроксипиримидиноны в качестве агонистов рецептора apj
EA201590058A1 (ru) Аналоги глюкагона
MA34453B1 (fr) Utilisation d'une eau appauvrie en deutèrium pour traiter la résistance à l'insuline
EA201990159A1 (ru) Биарилметильные гетероциклы
EA201790594A1 (ru) Противомикробные композиции и способы их применения
CL2013000733A1 (es) Compuestos derivados de arilalquilimidazol, moduladores selectivos de receptores alfa 2 adrenergicos; y composicion farmaceutica que los comprende.
FR3008747B1 (fr) Pompe d'eaux usees
EA201790098A1 (ru) Гербицидно действующие амиды арилкарбоновых кислот
EA201400210A1 (ru) Применение и агрохимическая композиция дибутиламидов карбоновой кислоты
EA201300737A1 (ru) Камера системы обработки крови, применение камеры, система шлангов для крови, а также система для обработки крови
EA200970472A1 (ru) Замещенные пиразолы, композиции, их содержащие, способ получения и применение
EA201390180A1 (ru) Конденсированные циклические соединения пиридина
EA201991490A1 (ru) Ароматические амиды карбоновых кислот в качестве антагонистов рецепторов брадикинина в1
EA201790191A1 (ru) Новые сульфониламинобензамидные соединения
FR2961402B1 (fr) Compositions contenant des arabinoxylo-oligosaccharides et leurs utilisations
FR3003164B1 (fr) Composition contenant de la superoxyde dismutase issue de vitis vinifera
FR3024902B1 (fr) Methode de determination de la stabilite d'un produit petrolier contenant des asphaltenes.
EA201792380A1 (ru) Новые ингибиторы epha4, нацеленные на его лиганд-связывающий домен